VANGUARD GROUP INC - HOOKIPA PHARMA INC ownership

HOOKIPA PHARMA INC's ticker is HOOK and the CUSIP is 43906K100. A total of 58 filers reported holding HOOKIPA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of HOOKIPA PHARMA INC
ValueSharesWeighting
Q3 2023$1,119,576
-30.2%
1,817,492
-0.2%
0.00%
Q2 2023$1,602,986
+24.3%
1,821,575
+4.0%
0.00%
Q1 2023$1,289,528
-9.1%
1,752,0760.0%0.00%
Q4 2022$1,419,182
-40.0%
1,752,076
-0.7%
0.00%
Q3 2022$2,364,000
-12.2%
1,763,621
+6.8%
0.00%
Q2 2022$2,692,000
+5.5%
1,651,731
+47.6%
0.00%
Q1 2022$2,551,000
+20.0%
1,118,871
+22.6%
0.00%
Q4 2021$2,126,000
-60.4%
912,562
+0.1%
0.00%
Q3 2021$5,370,000
-34.9%
911,699
+1.2%
0.00%
Q2 2021$8,255,000
-30.9%
901,149
+1.4%
0.00%
Q1 2021$11,953,000
+45.6%
888,680
+20.0%
0.00%
Q4 2020$8,212,000
+37.0%
740,459
+17.0%
0.00%
Q3 2020$5,993,000
+13.2%
632,815
+39.0%
0.00%
Q2 2020$5,292,000
+35.9%
455,355
-3.5%
0.00%
Q1 2020$3,895,000
-28.4%
471,909
+6.1%
0.00%
Q4 2019$5,438,000
+452.1%
444,646
+238.4%
0.00%
Q3 2019$985,000
+83.1%
131,391
+64.4%
0.00%
Q2 2019$538,00079,9160.00%
Other shareholders
HOOKIPA PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Redmile Group, LLC 1,842,902$17,452,0000.32%
Samsara BioCapital, LLC 116,602$1,104,0000.31%
Artal Group S.A. 599,616$5,678,0000.14%
HHLR ADVISORS, LTD. 943,254$8,933,0000.07%
DAFNA Capital Management LLC 22,061$209,0000.07%
Baker Brothers Advisors 700,481$6,634,0000.03%
ZACKS INVESTMENT MANAGEMENT 72,064$682,0000.01%
HOWLAND CAPITAL MANAGEMENT LLC 14,728$139,0000.01%
ETF MANAGERS GROUP, LLC 14,374$139,0000.00%
Squarepoint Ops LLC 12,699$120,0000.00%
View complete list of HOOKIPA PHARMA INC shareholders